Advertisement

Topics

With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial

19:00 EST 15 Nov 2017 | BioSpace

Moderna announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a mRNA-based personalized cancer vaccine.

Original Article: With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial

NEXT ARTICLE

More From BioPortfolio on "With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...